Refine by
Respiratory Distress Syndrome Suppliers & Manufacturers
33 companies found
based inSan Diego, CALIFORNIA (USA)
We are here to understand our clients' challenges and give them a solution. We put our clients first, aiming to be an extension of their organizations. Since our beginning in 1999, we have become a leader in web-based solutions designed to simplify ...
based inManchester, UNITED KINGDOM
Yourgene Health is a leading international molecular diagnostics group with an integrated portfolio of technologies and services to enable genomic medicine. Our mission to enable scientific advances to positively impact human health remains at the ...
The COVID-19 pandemic is an ongoing global pandemic. COVID-19 (also referred to as Coronavirus), is caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Coronaviruses are enveloped RNA viruses. They are names as such due to ...
based inParsippany, NEW JERSEY (USA)
At Zoetis, our purpose is to nurture our world and humankind by advancing care for animals. It’s an ambitious and humbling pursuit, but with a diverse and talented team supporting our customers all around the world, we’ve experienced 70 years of ...
Fostera PRRS is for the vaccination of healthy, susceptible swine in herds testing positive for porcine reproductive and respiratory syndrome (PRRS) virus as well as for negative pigs that may be exposed to PRRS virus (PRRSV) as an aid in preventing ...
based inMonmouth Junction, NEW JERSEY (USA)
MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...
Mefloquine (Mefloquin), an orally active and potent quinoline antimalarial agent, is an anti-SARS-CoV-2 entry inhibitor. Mefloquine is also a K+ channel (KvQT1/minK) antagonist with an IC50 of ~1 μM. Mefloquine can be used for malaria, systemic ...
based inBoston, MASSACHUSETTS (USA)
CervoMed is a clinical stage company dedicated to the development and commercialization of drug treatments for neurodegenerative diseases with a focus on the early stages of the neurodegenerative process. Until August 2023, CervoMed was known as ...
Our lead product candidate, Trans sodium crocetinate (TSC), is being developed to enhance the diffusion of oxygen to tissues with low oxygen levels, also known as hypoxia, a serious complication of many of medicine’s most intractable and ...
based inBad Ems, GERMANY
heyer medical AG is active in 80 countries on all continents of the world. With our headquarters in Germany, our own offices in China and the expertise of our employees working worldwide, we are able to react quickly to problems and to be on site ...
VS500S is a specially designed non-invasive ventilator for premature infant, neonate and pediatric. It provides comprehensive non-invasive ventilation to meet various respiratory management ...
based inBonaduz, SWITZERLAND
Since 1983 Hamilton Medical has been developing intelligent ventilation solutions that provide safer care for critically ill patients and make life easier for the people who care for them. Today, Hamilton Medical is a leading manufacturer of ...
Intelligent ventilation mode for passive and spontaneously breathing adult and pediatric patients. Automatically controls ventilator settings based on the targets for ventilation and oxygenation set by the clinician and on physiologic input from the ...
based inChangsha, CHINA
Founded in 2013, Micomme is headquartered in Changsha High-tech Zone. Its subsidiary, Shenzhen Micomme Medical Technology Development Co., Ltd., is located in the Nanshan District of Shenzhen. The company focuses on equipment innovation and chronic ...
Higher Treatment pressure, more leak compensation; *AST-Premium automatic synchronization technology, excellent man-machine synchronization; *Accurate oxygen concentration control, more efficient to improve ...
based inGaithersburg, MARYLAND (USA)
We are a biotechnology company that promotes improved health globally through the discovery, development and commercialization of innovative vaccines to prevent serious infectious diseases. We have more than a decade of experience contending with ...
Historically, we developed a vaccine candidate against MERS, a novel coronavirus first identified in 2012, as well as a vaccine candidate against SARS in 2005. In 2012, within weeks of obtaining the sequence of the circulating MERS strain, we ...
based inKing of Prussia, PENNSYLVANIA (USA)
Behring's parent company, CSL, was formed more than 100 years ago to save lives using the latest technologies. In the century since, CSL Behring has grown into a global biotechnology leader, driven by that same promise to save and improve lives. We ...
It is a sterile, preservative-free 20% w/v human albumin solution. It has a nominal osmolality of 130 mOsra/kg, is hypotonic and the pH is 6.7 to 7.3. It is hyperoncotic and hypo-osmotic compared to human serum. Albumex 20 is manufactured from human ...
based inGeffen, NETHERLANDS
Avant Medical offers laboratory healthcare professionals advice on making the right choice when it comes to the smartest products in their class. In this way, together we make a significant contribution to improved diagnostics and therefore better ...
Elevated levels of ACE activity occur in serum of patients with active sarcoidosis, and occasionally in premature infants with respiratory distress syndrome, in adults with tuberculosis, leprosy and ...
based inHaifa, ISRAEL
Pluristem Therapeutics Inc. is a clinical-stage regenerative medicine company using placental cells and a unique, proprietary, three-dimensional (3D) technology platform to develop cell therapies for conditions such as inflammation, muscle injuries, ...
Pluristem’s goal is to provide patients, physicians and healthcare systems around the globe with standardized, easy to use and highly effective PLX cell products that need no genetic or tissue matching prior to administration. We are active ...
based inFrederick, MARYLAND (USA)
Amivas (US), LLC is an Australian, Canadian, and US joint venture focused on the development, manufacturing, and commercialization of therapeutics for the treatment of infectious diseases. Amivas (US), LLC was formed in response to the urgent need ...
A Severe Malaria Treatment, Vital for the US Healthcare Community. No FDA-approved injectable malaria medication has been available in the US since IV quinidine was discontinued in early 2019. Artesunate for Injection fills this ...
based inSunnyvale, CALIFORNIA (USA)
We are developing cellular and cell-derived therapeutics for the treatment of unmet cardiovascular and pulmonary diseases. Our Mission: To improve the lives of patients with cardiovascular and pulmonary diseases through the development of ...
based inDerio, SPAIN
We develop new advanced therapy medicinal products, medical devices and dermocosmetics to improve people's quality of life. Histocell has two manufacturing facilities, both certified by the Spanish Drug Agency. One 2000 m sq for medical devices and ...
The HC016 platform is a treatment of acute lung injury, based on mesenchymal stem cells derived from adipose tissue (ASC), improved with proprietary Histocell ...
based inSalt Lake City, UTAH (USA)
We provide inspired infant care with our revolutionary Life Pulse Ventilator, the first high-frequency ventilator ever approved by the U.S. Food and Drug Administration (FDA) for clinical use (1988). Established in 1980, Bunnell has focused its ...
based inMelbourne, AUSTRALIA
Mesoblast is using its proprietary mesenchymal lineage cell technology platform to develop and commercialize innovative allogeneic cellular medicines to treat complex inflammatory diseases resistant to conventional standard of care. ...
based inSan Diego, CALIFORNIA (USA)
Stemedica Cell Technologies, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of progenitor cell and protein therapeutics for underserved medical conditions. Stemedica has developed a proprietary ...
Coronavirus disease 2019 (COVID-19) is a respiratory illness that can spread from person to person. This is a novel (or new) coronavirus that has not previously been seen in humans which has a wide range of symptoms reported with certain patients ...
based inSeattle, WASHINGTON (USA)
AVM Biotechnology is developing and advancing AVM0703, a proprietary formulation of concentrated dexamethasone. This formulation permits the very high dosing necessary to activate the release and trigger the production of the body’s supercharged ...
The American Lung Association describes acute respiratory distress syndrome (ARDS) as a life-threatening lung injury that allows fluid to leak into the lungs. Breathing becomes difficult and oxygen ...
based inExport, PENNSYLVANIA (USA)
Circadiance develops, manufactures and markets respiratory products for people with sleep-disordered breathing, who need non-invasive ventilation or who require monitoring. Circadiance is a pioneer in respiratory therapy specializing in positive ...
NeoPAP is a sophisticated CPAP delivery and treatment system developed to treat newborns and infants with respiratory distress syndrome (RDS) or who are recovering from RDS. ...